Skip to main content
. 2021 Jan 28;25:41. doi: 10.1186/s13054-021-03468-x

Fig. 2.

Fig. 2

Relative change (%) of myoglobin and CK during CS treatment. CK creatine kinase, CS Cytosorb®, green dots: decrease of CK during CS treatment (= group 1), red dots: increase of CK during CS treatment (= group 2)